RCAS1 decidual immunoreactivity and RCAS1 serum level during cesarean section with respect to the progression of labor

American Journal of Reproductive Immunology

Volumn 59, Issue 2, 2008, Pages 152-158

  Wicherek, Lukasz ^a   Basta, Pawel ^a   Galazka, Krystyna ^a   Mak, Pawel ^a   Dancewicz, Lukasz ^a   Kalinka, Jaroslaw ^b  

^a JAGIELLONIAN UNIVERSITY   (Poland)

^b MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

Decidua; Immune tolerance; RCAS1

Indexed keywords

CELL MEMBRANE PROTEIN; PROTEIN RCAS1; RECEPTOR BINDING CANCER ANTIGEN EXPRESSED ON SISO CELL PROTEIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CESAREAN SECTION; CONTROLLED STUDY; DECIDUA; FEMALE; HUMAN; HUMAN EXPERIMENT; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOLOGICAL TOLERANCE; IMMUNOREACTIVITY; LABOR; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; STATISTICAL SIGNIFICANCE;

ADULT; ANTIGENS, NEOPLASM; CESAREAN SECTION; DECIDUA; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LABOR, OBSTETRIC; PREGNANCY;

EID: 38349047753     PISSN: 10467408     EISSN: 16000897     Source Type: Journal    
DOI: 10.1111/j.1600-0897.2007.00540.x     Document Type: Article

References (31)

1. Szekeres-Bartho J, Varga P, Pacsa AS: Immunologic factors contributing to the initiation of labor-lymphocyte reactivity in term labor and threatened preterm delivery. Am J Obstet Gynecol 1986; 155: 108-112.
2. Abadia-Molina AC, Ruiz C, Montes MJ, King A, Loke YW, Olivares EG: Immune phenotype and cytotoxic activity of lymphocytes from human term decidua against trophoblast. J.Reprod Immunol 1996; 31: 109-123.
3. Steinborn A, Sohn C, Sayehli C, Baudendistel A, Huwelmeier D, Solbach C, Schmitt E, Kaufmann M: Spontaneous labor at term is associated with fetal monocyte activation. Clin Exp Immunol 1999; 117: 147-152.
4. Wicherek L, Klimek M, Dutsch-Wicherek M: The level of maternal immune tolerance and fetal maturity. Neuro Endocrinol Lett 2005; 26: 561-566.
5. Kalinka J, Sobala W, Wasiela M, Brzezinska-Blaszczyk E: Decreased proinflmatory cytokines in cervicovaginal fluid as measured in midgestation, are associated with preterm delivery. Am J Reprod Immunol 2005; 54: 70-76.
6. Osmers RG, Blaser J, Kuhn W, Tschesche H: Interleukin-8 synthesis and the onset of labor. Obstet Gynecol 1995; 86: 223-229.
7. Pongcharoen S, Searle RF, Bulmer JN: Placental Fas and Fas ligand expression in normal early, term and molar pregnancy. Placenta 2004; 25: 321-330.
8. Balkundi DR, Hanna N, Hileb M, Dougherty J, Sharma S: Labor-associated changes in Fas ligand expression and function in human placenta. Pediatr Res 2000; 47: 301-308.
9. Hackmon R, Hallak M, Krup M, Weitzman D, Sheiner E, Kaplan B, Weinstein Y: HLA-G antigen and partMrition: maternal serum, fetal serum and amniotic fluid levels during pregnancy. Fetal Diagn Ther 2004; 19: 404-409.
10. Ohshima K, Nakashima M, Sonoda K, Kikuchi M, Watanabe T: Expression of RCAS1 and FasL in human trophoblasts and uterine glands during pregnancy: The possible role in immune privilege. Clin Exp Immunol 2001; 123: 481-486.
11. Wicherek L, Dutsch-Wicherek M, Mak P, Klimek M: The role of RCAS1 and oxytocinase in immune tolerance during pregnancy. Fetal Diagn Ther 2005; 20: 420-425.
12. Wicherek L, Klimek M, Dutsch-Wicherek M, Kolodziejski L, Skotniczny K: The molecular changes during placenta detachment. Eur J Obstet Gynecol Reprod Biol 2006; 125: 171-175.
13. Wicherek L, Galazka K, Lazar A: RCAS1 decidual immunoreactivity during placental abruption: Immune cell presence and activity. Am J Reprod Immunol 2007; 58: 46-55.
14. Nakashima M, Sonoda K, Watanabe T: Inhibition of cell growth and induction of apoptotic cell death by the human tumor-associated antigen RCAS1. Nat Med 1999; 5: 938-942.
15. Sonoda K, Kaku T, Hirakawa T, Kobayashi H, Amada S, Sakai K, Nakashima M, Watanabe T, Nakano H: The clinical significance of tumor-associated antigen RCAS1 expression in the normal, hyperplastic, and malignant uterine endometrium. Gynecol Oncol 2000; 79: 424-429.
16. Sonoda K, Miyamoto S, Hirakawa T, Yagi H, Yotsumoto F, Nakashima M, Watanabe T, Nakano H: Association between RCAS1 expression and microenvironmental immune cell death in uterine cervical cancer. Gynecol Oncol 2005; 97: 772-779.
17. Nakabayashi H, Nakashima M, Hara M, Toyonaga S, Yamada SM, Park KC, Shimizu K: Clinico-pathological significance of RCAS1 expression in gliomas: A potential mechanism of tumor immune escape. Cancer Lett 2007; 246: 182-189.
18. Sonoda K, Miyamoto S, Hirakawa T, Yagi H, Yotsumoto F, Nakashima M, Watanabe T, Nakano H: Clinical significance of RCAS1 as a biomarker of uterine cancer. Gynecol Oncol 2006; 103: 924-931.
19. Kawano Y, Kaku T, Sonoda K, Hirakawa T, Kobayashi H, Ohishi Y, Nakano H: Expression of RCAS1 in female genital organs. Int J Gynecol Pathol 2005; 24: 330-334.
20. Wicherek L, Popiela TJ, Galazka K, Dutsch-Wicherek M, Oplawski M, Basta A, Klimek M: Metallothionein and RCAS1 expression in comparison to immunological cells activity in endometriosis, endometrial adenocarcinoma and endometrium according to menstrual cycle changes. Gynecol Oncol 2005; 99: 622-630.
21. Wicherek L, Basta P, Sikora J, Galazka K, Rytlewski K, Grabiec M, Lazar A, Kalinka J: RCAS1 decidual immunoreactivity in severe preeclampsia: immune cell presence and activity. Am J Reprod Immunol 2007; 58: 358-366.
22. Sharma S, Murphy SP, Barnea ER: Genes regulating implantation and fetal development: A focus on mouse knockout models. Front Biosci 2006; 11: 2123-2137.
23. Sindram-Trujillo A, Scherjon S, Kanhai H, Roelen D, Class F: Increased T-cell activation in decidua parietalis compared to decidua basalis in uncomplicated human term pregnancy. Am J Reprod Immunol 2003; 49: 261-268.
24. Sindram-Trujillo AP, Scherjon SA, Van Hulst-van Miert PP, Kanhai HH, Roelen DL, Claas FH: Comparison of decidual leukocytes following spontaneous vaginal delivery and elective cesarean section in uncomplicated human term pregnancy. J.Reprod Immunol 2004; 62: 125-137.
25. Sindram-Trujillo AP, Scherjon SA, van-Hulst-van Miert PP, Van Schip J, Kanhai HH, Roelen DL, Claas FH: Differential distribution of NK cells in decidua basalis compared with decidua parietalis after uncomplicated human term pregnancy. Hum Immunol 2003; 64: 921-929.
26. Tskitishvili E, Komoto Y, Kinugasa Y, Kanagawa T, Song M, Mimura K, Tomimatsu T, Kimura T, Shimoya K: The human tumor-associated antigen RCAS1 in pregnancies complicated by preeclampsia. J.Reprod Immunol 2007; in press.
27. Wilczynski JR, Tchorzewski H, Banasik M, Glowacka E, Wieczorek A, Lewkowicz P, Malinowski A, Szpakowski M, Wilczynski J: Lymphocyte subset distribution and cytokines secretion in third trimester decidua in normal pregnancy and preeclampsia. Eur J Obstet Gynecol Reprod Biol 2003; 109: 8-15.
28. Raghupathy R, Al Mutawa E, Makhseed M, Azizieh F, Szekeres-Bartho J: Modulation of cytokine production by dydrogesterone in lymphocytes from women with recurrent miscarriage. BJOG 2005; 112: 1096-1101.
29. Saito S, Sakai M, Sasaki Y, Tanebe K, Tsuda H, Michimata T: Quantitative analysis of peripheral blood Th0, Th1, Th2 and the Th1:TH2 cell ratio during normal human pregnancy and preeclampsia. Clin Exp Immunol 1999; 117: 550-555.
30. Azizieh F, Raghupathy R, Makhseed M: Maternal cytokine production patterns in women with pre-eclampsia. Am J Reprod Immunol 2005; 54: 30-37.
31. Bachmayer N, Rafik-Hamad R, Liszka L, Bremme K, Sverremark-Ekstrom E: Aberrant uterine natural killer (NK)-cell expression and altered placental and serum levels of the NK-cell promoting cytokine interleukin-12 in pre-eclampsia. Am J Reprod Immunol 2006; 56: 292-301.